Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet glycoprotein VI: its structure and function.

Masaaki Moroi1, Stephanie M Jung

  • 1Department of Protein Biochemistry, Institute of Life Science, Kurume University, 2432-3 Aikawa-machi, Kurume, Fukuoka 839-0861, Japan. mmoroi@lsi.kurume-u.ac.jp

Thrombosis Research
|September 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet Receptor Glycoprotein VI-Dimer Is Overexpressed in Patients with Atrial Fibrillation at High Risk of Ischemic Stroke.

TH open : companion journal to thrombosis and haemostasis·2023
Same author

Role of heat shock protein 47 in platelet glycoprotein VI dimerization and signaling.

Research and practice in thrombosis and haemostasis·2023
Same author

Factor XIII is a newly identified binding partner for platelet collagen receptor GPVI-dimer-An interaction that may modulate fibrin crosslinking.

Research and practice in thrombosis and haemostasis·2022
Same author

Platelet surface receptor glycoprotein VI-dimer is overexpressed in stroke: The Glycoprotein VI in Stroke (GYPSIE) study results.

PloS one·2022
Same author

Dimers of the platelet collagen receptor glycoprotein VI bind specifically to fibrin fibers during clot formation, but not to intact fibrinogen.

Journal of thrombosis and haemostasis : JTH·2021
Same author

Activation-induced changes in platelet surface receptor expression and the contribution of the large-platelet subpopulation to activation.

Research and practice in thrombosis and haemostasis·2020
Same journal

Apoptotic versus procoagulant platelets: similar "necrotic" phenotype and procoagulant activity in vitro, but distinct adhesive protein composition.

Thrombosis research·2026
Same journal

Heatstroke-induced coagulopathy: A scoping review of therapeutic strategies and outcome reporting.

Thrombosis research·2026
Same journal

Mapping thrombus habitat: Non-contrast MRI radiomics and pixel-tile histomics approach to track venous thrombosis evolution in mice.

Thrombosis research·2026
Same journal

A study protocol for a randomised controlled trial evaluating the safety and efficiency of the YEARS algorithm versus computed tomography pulmonary angiography only for suspected acute pulmonary embolism in patients with cancer: the Hydra Study.

Thrombosis research·2026
Same journal

Associating the phenotypic expression of platelets with disease type through image-based single-cell profiling.

Thrombosis research·2026
Same journal

The mechanisms of contractile dysfunction following chronic limited platelet activation in (pro)thrombotic conditions.

Thrombosis research·2026
See all related articles

Glycoprotein VI (GPVI) is crucial for collagen-induced platelet activation and thrombus formation. Despite its importance, GPVI deficiency doesn't cause severe bleeding, highlighting a complex role in hemostasis.

Area of Science:

  • Biochemistry
  • Hematology
  • Immunology

Background:

  • Glycoprotein (GP) VI is a key platelet collagen receptor.
  • GPVI functions as a complex with the Fc receptor (FcR) gamma-chain.
  • It initiates signaling via tyrosine phosphorylation of the FcR gamma-chain ITAM.

Purpose of the Study:

  • To investigate the role of GPVI in collagen-induced platelet activation and thrombus formation.
  • To understand the signaling pathway initiated by GPVI.
  • To reconcile the essential role of GPVI in vitro with the lack of severe bleeding in deficient individuals.

Main Methods:

  • Studies involving patients with GPVI-deficient platelets.
  • Analysis of platelet aggregation and thrombus formation under flow conditions.

Related Experiment Videos

  • Investigation of tyrosine phosphorylation signaling pathways.

    • Main Results:

    • GPVI-deficient platelets show impaired collagen-induced aggregation and thrombus formation.
    • GPVI forms a dimeric complex with FcR gamma-chain for high-affinity collagen binding.
    • Despite its critical role, GPVI deficiency does not lead to a significant bleeding tendency.

    Conclusions:

    • GPVI is indispensable for efficient collagen-mediated platelet activation and thrombus development.
    • The absence of a bleeding phenotype in GPVI deficiency suggests compensatory mechanisms or alternative pathways in vivo.
    • Further research into this dichotomy is needed for a comprehensive understanding of thrombus formation.